Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Eli Lilly (NY: LLY )

525.19 -13.10 (-2.43%)
Official Closing Price Updated: 7:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,266,121
Open 536.00
Bid (Size) 516.58 (1)
Ask (Size) 525.79 (8)
Prev. Close 538.29
Today's Range 516.57 - 537.34
52wk Range 302.14 - 601.84
Shares Outstanding N/A
Dividend Yield 0.86%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Eli Lilly Stock Was Looking Sickly Today
Investors weren't necessarily satisfied with their company's latest asset buy. 
Via The Motley Fool
Crude Oil Moves Higher; POINT Biopharma Global Shares Jump
U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities

Performance

YTD
+43.89%
+43.89%
1 Month
-5.91%
-5.91%
3 Month
+12.77%
+12.77%
6 Month
+48.10%
+48.10%
1 Year
+63.33%
+63.33%

More News

Read More
Why Eli Lilly Stock Is Trading Lower Today
Via Benzinga
Why Shares of Point Biopharma Global Are Soaring Tuesday
Via The Motley Fool
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
Via Benzinga
Analyst Ratings for Eli Lilly
Via Benzinga
FDA Declines To Approve Eli Lilly's Eczema Drug
Via Benzinga
Exposures Product Safety
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Down Over 200 Points; US Job Openings Rise In August
Via Benzinga
Topics Stocks
Exposures US Equities
Point Biopharma Stock Nearly Doubles On Eli Lilly Deal
Via Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Vericity, Inc. (Nasdaq - VERY), POINT Biopharma Global, Inc. (Nasdaq - PNT), Blue Apron Holdings, Inc. (Nasdaq - APRN), Chico’s FAS, Inc. (NYSE - CHS)
From Brodsky & Smith LLC
Via GlobeNewswire
S&P 500 Forecast: Stocks Drop As Treasury Yields Surge
Via Talk Markets
Topics Stocks
Exposures US Equities
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
Via Benzinga
Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Falls Over 100 Points; McCormick Sales Miss Views
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Point Biopharma Stock Launches 84% On Eli Lilly's $1.4 Billion Takeover
Via Investor's Business Daily
Why Is Cancer Treatment Focused POINT Biopharma Stock Trading Higher Today?
Via Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
Via Benzinga
Why Is Point Biopharma (PNT) Stock Up 84% Today?
Via InvestorPlace
Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%
Via Investor's Business Daily
Why Shares of Structure Therapeutics Are Up Monday
Via The Motley Fool
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
Via InvestorPlace
Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns
Via InvestorPlace
Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)
Via AB Newswire
Topics Death
Exposures Death Product Safety
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.